Evidence map›Paper›PMID 30409231›Full record

SynthesisThe British journal of nutrition2018

Effect of dietary interventions in mild cognitive impairment: a systematic review.

Andrea M McGrattan, Claire T McEvoy, Bernadette McGuinness, Michelle C McKinley, Jayne V Woodside

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in The British journal of nutrition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 6 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 6 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. A standardized combination ofFrontiers in nutrition · 2025
    Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Andrea M McGrattan1Centre for Public Health,Queen's University Belfast,BelfastBT12 6BJ,UK.ORCID 0000-0003-1521-213X
Claire T McEvoy1Centre for Public Health,Queen's University Belfast,BelfastBT12 6BJ,UK.
Bernadette McGuinness1Centre for Public Health,Queen's University Belfast,BelfastBT12 6BJ,UK.
Michelle C McKinley1Centre for Public Health,Queen's University Belfast,BelfastBT12 6BJ,UK.
Jayne V Woodside1Centre for Public Health,Queen's University Belfast,BelfastBT12 6BJ,UK.
Queen's University Belfast · GB

Funding

Wellcome Trust 202097
6 · The paper itself

Abstract

Diet has been investigated in relation to its ability to promote cognitive function. However, evidence is currently limited and has rarely been systematically reviewed, particularly in a mild cognitive impairment (MCI) population. This review examined the effect of diet on cognitive outcomes in MCI patients. A total of five databases were searched to find randomised controlled trial (RCT) studies, with diet as the main focus, in MCI participants. The primary outcome was incident dementia and/or Alzheimer's disease (AD) and secondary outcomes included cognitive function across different domains using validated neuropsychological tests. Sixteen studies met the inclusion criteria. There was a high degree of heterogeneity relating to the nature of the dietary intervention and cognitive outcomes measured, thus making study comparisons difficult. Supplementation with vitamin E (one study, n 516), ginkgo biloba (one study, n 482) or Fortasyn Connect (one study, n 311) had no significant effect on progression from MCI to dementia and/or AD. For cognitive function, the findings showed some improvements in performance, particularly in memory, with the most consistent results shown by B vitamins, including folic acid (one study, n 266), folic acid alone (one study, n 180), DHA and EPA (two studies, n 36 and n 86), DHA (one study, n 240) and flavonol supplementation (one study, n 90). The findings indicate that dietary factors may have a potential benefit for cognitive function in MCI patients. Further well-designed trials are needed, with standardised and robust measures of cognition to investigate the influence of diet on cognitive status.

Indexed as

DietAlzheimer DiseaseAttentionBiomarkersCognitionCognitive DysfunctionDementiaDietary SupplementsDisease ProgressionDocosahexaenoic AcidsEicosapentaenoic AcidExecutive FunctionFolic AcidGinkgo bilobaHumansLanguageBiomarkersDocosahexaenoic AcidsEicosapentaenoic AcidFolic AcidFortasyn ConnectPhospholipidsVitamin EAD Alzheimer’s diseaseDietGI glycaemic indexHF high flavonolHR hazard ratioInterventionsLF low flavonolLifestyleMCI mild cognitive impairmentMild cognitive impairmentMMSE Mini Mental State ExaminationRCT randomised controlled trialSystematic reviews

Identifiers

PMID30409231
PMCPMC6679717
OpenAlexW2899596986

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.